This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Reverse-payment patent settlements in the pharmaceutical industry: An analysis of U.S. antitrust law and EU competition law

Spring 2014, The Antitrust Bulletin

Share this article: